+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Pollen Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768040
  • Report
  • 166 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Allergy Therapeutics Plc
  • Anergis SA
  • ASIT Biotech SA
  • IQVIA Holdings Inc
  • Laboratorios LETI SL
  • Stallergenes Greer plc
  • MORE
The global clinical trial report- “2019 Pollen Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pollen Allergy. It presents in-depth analysis of Pollen Allergy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Pollen Allergy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Pollen Allergy clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Pollen Allergy

The research work is prepared through extensive and continuous research on Pollen Allergy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Pollen Allergy patients are identified
  • The report includes panorama of Pollen Allergy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Pollen Allergy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergy Therapeutics Plc
  • Anergis SA
  • ASIT Biotech SA
  • IQVIA Holdings Inc
  • Laboratorios LETI SL
  • Stallergenes Greer plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Pollen Allergy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Pollen Allergy Clinical Trials by Region
2.2.2 Average Enrollment of Pollen Allergy Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Pollen Allergy Treatment, 2019

3. Region wise Pollen Allergy Clinical Trials
3.1 Asia Pacific Pollen Allergy Clinical Trials by Country
3.2 Europe Pollen Allergy Clinical Trials by Country
3.3 North America Pollen Allergy Clinical Trials by Country
3.4 Middle East and Africa Pollen Allergy Clinical Trials by Country
3.5 South and Central America Pollen Allergy Clinical Trials by Country

4. Pollen Allergy Clinical Trial Trends
4.1 Start Year wise Pollen Allergy Clinical Trials
4.2 Phase wise Pollen Allergy Clinical Trials
4.3 Trial Status wise Pollen Allergy Clinical Trials
4.4 Trial Type wise Pollen Allergy Clinical Trials

5. Pollen Allergy Average Enrollment Trends
5.1 Average Enrollment in Pollen Allergy Trials by Year
5.2 Average Enrollment in Pollen Allergy Trials by Phase
5.3 Average Enrollment in Pollen Allergy Trials by Status
5.4 Average Enrollment in Pollen Allergy Trials by Type of Trial

6. Companies Participating in Pollen Allergy Clinical Trials
6.1 Pollen Allergy Trials by Sponsor Type
6.2 Pollen Allergy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Pollen Allergy Trials- Phase 1
7.2 Pollen Allergy Trials- Phase 2
7.3 Pollen Allergy Trials- Phase 3
7.4 Pollen Allergy Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Pollen Allergy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Pollen Allergy Clinical Trials and Enrolment
Figure 5: Europe - Country wise Pollen Allergy Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Pollen Allergy Clinical Trials and Enrolment
Figure 7: North America - Country wise Pollen Allergy Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Pollen Allergy Clinical Trials and Enrolment
Figure 9: Pollen Allergy Clinical Trials by Phase
Figure 10: Pollen Allergy Clinical Trials by Trial Status
Figure 11: Pollen Allergy Clinical Trials by Type
Figure 12: Pollen Allergy Clinical Trials by Sponsor Type
Figure 13: Pollen Allergy Clinical Trials by Leading Sponsors
Figure 14: Pollen Allergy Average Enrollment by Phase
Figure 15: Pollen Allergy Average Enrollment by Trial Status
Figure 16: Pollen Allergy Average Enrollment by Type
Figure 17: Pollen Allergy- Average Enrolment by Type of Sponsors
Figure 18: Pollen Allergy- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Pollen Allergy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Pollen Allergy Clinical Trials and Enrolment
Table 5: Europe - Country wise Pollen Allergy Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Pollen Allergy Clinical Trials and Enrolment
Table 7: North America - Country wise Pollen Allergy Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Pollen Allergy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Pollen Allergy Average Enrollment by Phase
Table 15: Pollen Allergy Average Enrollment by Trial Status
Table 16: Pollen Allergy Average Enrollment by Type
Table 17: Pollen Allergy- Average Enrolment by Type of Sponsors
Table 18: Pollen Allergy- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergy Therapeutics Plc
  • Allied Research International Inc
  • Anergis SA
  • ASIT Biotech SA
  • Circassia Pharmaceuticals Plc
  • Droege International Group AG
  • IQVIA Holdings Inc
  • Laboratorios LETI SL
  • Stallergenes Greer plc
  • The Lundbeck Foun
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768040
Adroll
adroll